Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.89B |
| 2 |
Walt Disney
DIS
|
+$1.58B |
| 3 |
Amazon
AMZN
|
+$1.49B |
| 4 |
ASML
ASML
|
+$1.45B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.36B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$9B |
| 2 |
UnitedHealth
UNH
|
+$3.08B |
| 3 |
HES
Hess
HES
|
+$2.6B |
| 4 |
Apple
AAPL
|
+$1.98B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.24B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Healthcare | 12.12% |
| 3 | Financials | 10.96% |
| 4 | Consumer Discretionary | 10.79% |
| 5 | Communication Services | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Bio-Techne
TECH
$11.3B
| $78M | 0.01% |
1,107,977
-82,131
| -7% | -$5.88M |
|
1152
MGM Resorts International
MGM
$11.2B
| $77.8M | 0.01% |
1,647,034
-27,160
| -2% | -$1.19M |
|
1153
BGC Group
BGC
$4.89B
| $77.5M | 0.01% |
9,975,381
+1,188,507
| +14% | +$8.81M |
|
1154
Construction Partners
ROAD
$6.77B
| $77.5M | 0.01% |
1,380,070
+746,218
| +118% | +$35.3M |
|
1155
NCR Atleos
NATL
$3.44B
| $77.3M | 0.01% |
3,914,379
+1,307,819
| +50% | +$28M |
|
1156
BioNTech
BNTX
$23.5B
| $77M | 0.01% |
834,390
+697,426
| +509% | +$66.9M |
|
1157
Macy's
M
$6.68B
| $76.8M | 0.01% |
3,841,027
+916,279
| +31% | +$17.7M |
|
1158
NCR Voyix
VYX
$1.14B
| $76.3M | 0.01% |
6,037,738
+1,035,533
| +21% | +$14.9M |
|
1159
Brown & Brown
BRO
$23.9B
| $75.9M | 0.01% |
867,501
+31,696
| +4% | +$2.55M |
|
|
OPTU
1160
Optimum Communications Inc
OPTU
$301M
| $75.9M | 0.01% |
29,068,360
+21,658,403
| +292% | +$54.5M |
|
|
CERE
1161
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $75.8M | 0.01% |
1,792,350
-7,899,501
| -82% | -$332M |
|
1162
Tango Therapeutics
TNGX
$4.41B
| $75.4M | 0.01% |
9,491,655
-295,695
| -3% | -$3.17M |
|
1163
AtriCure
ATRC
$2.11B
| $75.4M | 0.01% |
2,477,275
+2,401,389
| +3,164% | +$80.4M |
|
1164
Silicon Motion
SIMO
$8.68B
| $75M | 0.01% |
974,523
+390,022
| +67% | +$26.6M |
|
|
MRUS
1165
DELISTED
Merus
MRUS
| $74.9M | 0.01% |
1,662,545
+932,092
| +128% | +$37.8M |
|
1166
Frontline
FRO
$8.85B
| $74.8M | 0.01% |
3,200,076
+2,049,692
| +178% | +$46.3M |
|
|
THS
1167
DELISTED
Treehouse Foods
THS
| $74.3M | 0.01% |
1,907,519
+553,131
| +41% | +$21.9M |
|
1168
Idacorp
IDA
$8.2B
| $74.3M | 0.01% |
799,633
-222,870
| -22% | -$20.4M |
|
1169
Acadia Pharmaceuticals
ACAD
$5.03B
| $73.8M | 0.01% |
3,993,806
-1,271,552
| -24% | -$31.5M |
|
1170
Lantheus
LNTH
$6.59B
| $73.6M | ﹤0.01% |
1,182,498
-1,148,636
| -49% | -$67.6M |
|
1171
BHP
BHP
$230B
| $73.5M | ﹤0.01% |
1,274,855
-186,300
| -13% | -$11.1M |
|
|
EVBG
1172
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $73.4M | ﹤0.01% |
2,108,728
-37,937
| -2% | -$1.07M |
|
1173
Spectrum Brands
SPB
$2.07B
| $73.2M | ﹤0.01% |
822,723
-35,654
| -4% | -$2.91M |
|
1174
Encore Capital Group
ECPG
$2.13B
| $73.1M | ﹤0.01% |
1,603,372
-75,720
| -5% | -$3.73M |
|
|
PPLI
1175
People Inc
PPLI
$3.1B
| $73M | ﹤0.01% |
1,668,460
+28,487
| +2% | +$1.23M |
|
Similar funds
Fidelity Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Fidelity Investments held 5,856 positions worth $1.49T, up 14% from $1.3T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Fidelity Investments's Q1 2024 filing shows 420 new, 2,673 increased, 1,840 reduced and 491 closed positions. Its largest new stake was Astera Labs: 16,403,971 shares worth $1.22B. The largest sale was NVIDIA, an estimated $9B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2024 buy was Astera Labs: 16,403,971 shares worth $1.22B.
- Fidelity Investments added most to Broadcom in Q1 2024, an estimated $1.89B increase.
- Fidelity Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $9B.
- Fidelity Investments fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $907M.
- Fidelity Investments's ten largest holdings make up 33% of its $1.49T portfolio in Q1 2024.
- Fidelity Investments opened 420 new positions and closed 491 in Q1 2024.
- Fidelity Investments's portfolio value rose 14% quarter-over-quarter to $1.49T.
Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.